Abstract
Blood pressure (BP) control rates among US adults taking antihypertensive medication have not increased over the past decade. Many adults require 2 or more classes of antihypertensive medication to achieve guideline-recommended BP goals, but the proportion of US adults taking antihypertensive medication monotherapy, versus combination therapy, has not been quantified using contemporary data. We analyzed data from 2005 to 2008, 2009 to 2012, and 2013 to 2016 National Health and Nutrition Examination Surveys to determine trends in monotherapy and combinations of antihypertensive medication classes among US adults age ≥20 years with hypertension taking antihypertensive medication (n=7837). The proportion of US adults taking antihypertensive medication with uncontrolled BP (ie, systolic BP ≥140 or diastolic BP ≥90 mm Hg) was 32.3%, 30.2%, and 31.0% in 2005 to 2008, 2009 to 2012, and 2013 to 2016, respectively (Ptrend=0.37). Between 2005 to 2008 and 2013 to 2016, there was no evidence of changes in the proportions of US adults taking antihypertensive monotherapy (39.5%-40.4%, Ptrend=0.67), dual-therapy (37.9%-38.3%, Ptrend=0.75), triple-therapy (17.6%-16.5%, Ptrend=0.36), or quadruple-therapy (4.4%-4.3%, Ptrend=0.93). Between 2005 t...Continue Reading
References
Apr 9, 2002·Lancet·Björn DahlöfUNKNOWN LIFE Study Group
May 16, 2003·JAMA : the Journal of the American Medical Association·Aram V ChobanianUNKNOWN National High Blood Pressure Education Program Coordinating Committee
Jun 28, 2003·BMJ : British Medical Journal·M R LawR E Jordan
Dec 6, 2003·JAMA : the Journal of the American Medical Association·Carl J PepineUNKNOWN INVEST Investigators
Sep 13, 2005·Lancet·Björn DahlöfUNKNOWN ASCOT Investigators
Nov 15, 2005·QJM : Monthly Journal of the Association of Physicians·B WilliamsS de Lusignan
Jan 5, 2006·Circulation·Qiuping GuVicki Burt
Dec 21, 2006·Hypertension·Azra Mahmud, John Feely
Jan 3, 2008·Public Health Nutrition·Norbert G SchwarzKerstin Klipstein-Grobusch
May 3, 2008·American Journal of Hypertension·Qiuping GuCharles F Dillon
Dec 5, 2008·The New England Journal of Medicine·Kenneth JamersonUNKNOWN ACCOMPLISH Trial Investigators
Dec 19, 2008·The Journal of Clinical Hypertension·William C CushmanUNKNOWN ALLHAT Collaborative Research Group
Mar 11, 2009·The American Journal of Medicine·David S WaldNicholas J Wald
May 6, 2009·Annals of Internal Medicine·Andrew S LeveyUNKNOWN CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration)
Mar 17, 2010·The New England Journal of Medicine·William C CushmanFaramarz Ismail-Beigi
May 27, 2010·JAMA : the Journal of the American Medical Association·Brent M EganR Neal Axon
Nov 12, 2010·Journal of Managed Care Pharmacy : JMCP·Boyang BianPatricia R Wigle
Mar 4, 2011·The Journal of Clinical Hypertension·Alan H GradmanUNKNOWN American Society of Hypertension Writing Group
Oct 24, 2012·Circulation·Qiuping GuSarah Yoon
Apr 19, 2013·International Journal of Audiology·C Spankovich, C G Le Prell
Nov 14, 2013·Circulation·David C GoffGordon F Tomaselli
Dec 20, 2013·JAMA : the Journal of the American Medical Association·Paul A JamesEduardo Ortiz
Nov 10, 2015·The New England Journal of Medicine·UNKNOWN SPRINT Research GroupWalter T Ambrosius
Jan 1, 2015·Clinical Hypertension·Noah JarariLaxmi Teja Peela
May 23, 2017·American Journal of Hypertension·Shreya J Shah, Randall S Stafford
Aug 30, 2017·Hypertension·Yiyi Zhang, Andrew E Moran
Nov 18, 2017·Journal of the American College of Cardiology·Paul K WheltonJackson T Wright
Aug 19, 2018·JAMA : the Journal of the American Medical Association·Ruth WebsterUNKNOWN TRIUMPH Study Group
Apr 17, 2019·European Heart Journal·Bryan Williams, Giuseppe Mancia
May 7, 2019·Journal of Hypertension·Abdul SalamAnthony Rodgers
Jul 20, 2019·Lancet·Ivor J BenjaminMichael Brainin
Citations
Mar 10, 2020·Hypertension·Waleed E Ali, George L Bakris
Aug 29, 2020·Advances in Therapy·Yingyi ZhangHongliang Cong
Apr 23, 2020·JAMA : the Journal of the American Medical Association·Safiya RichardsonTheodoros P Zanos
Aug 28, 2020·Expert Review of Cardiovascular Therapy·Angel de la CruzJonathan N Bella
Apr 26, 2020·Journal of Human Hypertension·Catherine G DeringtonAdam P Bress
Apr 3, 2020·Journal of the American Heart Association·Rami SommersteinChristoph Gräni
Nov 17, 2020·Hypertension·Jaejin AnKristi Reynolds
Sep 11, 2020·Annals of Internal Medicine·Stephen P JuraschekKenneth J Mukamal
Feb 5, 2021·Frontiers in Neuroendocrinology·Ioannis LiampasEfthimios Dardiotis
Nov 19, 2020·JAMA Network Open·Calvin L ColvinAdam Bress
Oct 14, 2020·American Journal of Hypertension·Sascha DublinBruce M Psaty
Jan 29, 2021·Clinical Pharmacology and Therapeutics·Karen Melissa Hallow, Ishaan Dave
Mar 30, 2021·Hypertension·Seng Chan YouSungha Park
Apr 3, 2021·Clinical Kidney Journal·Jordana B CohenMatthew A Sparks
Jan 5, 2021·Journal of Cardiovascular Pharmacology·Danyelle S MiottoSandra L Amaral
Nov 7, 2020·American Journal of Hypertension·Sean Hennessy, Jordana B Cohen
May 6, 2021·Amino Acids·Pawan Kumar RaghavDinesh Kumar
May 20, 2021·Journal of the American Heart Association·Adam P BressApril F Mohanty
Aug 20, 2021·Advances in Therapy·Zhen LiRuiqing Zhang
Sep 16, 2021·JAMA Network Open·Cedric EdwardsManish M Sood
Oct 14, 2021·Hypertension·Swati SakhujaPaul Muntner
Oct 16, 2021·Journal of Human Hypertension·Jonathan R SalikThomas H McCoy
Oct 30, 2021·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Julie RouetteLaurent Azoulay